col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


28 Results       Page 1

 [1] 
Wiley: BioEssays
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―10 NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2 Baohui Zhu, Ryota Ouda, Yusuke Kasuga, Paul de Figueiredo, Koichi S. Kobayashi
2 [GO] 2023―Jun―10 Jerne's “immune network theory”, of interacting anti-idiotypic antibodies applied to immune responses during COVID-19 infection and after COVID-19 vaccination Sven Kurbel
3 [GO] 2022―Jul―18 Molecular dynamics studies reveal structural and functional features of the SARS-CoV-2 spike protein Ludovico Pipitò, Roxana-Maria Rujan, Christopher A. Reynolds, Giuseppe Deganutti
4 [GO] 2021―Nov―23 The SARS-CoV-2 origin dilemma: Zoonotic transfer or laboratory leak? Blanca E. Ruiz-Medina, Armando Varela-Ramirez, Robert A. Kirken, Elisa Robles-Escajeda
5 [GO] 2021―Oct―26 There is still no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (10.1002/bies.202100137) Alexander Tyshkovskiy, Alexander Y. Panchin
6 [GO] 2021―Jul―30 The genetic structure of SARS-CoV-2 is consistent with both natural or laboratory origin: Response to Tyshkovskiy and Panchin (10.1002/bies.202000325) Yuri Deigin, Rossana Segreto
7 [GO] 2021―Jul―26 Personalized health and the coronavirus vaccines-Do individual genetics matter? Bianca N. Valdés-Fernández, Jorge Duconge, Ana M. Espino, Gualberto Ruaño
8 [GO] 2021―Jul―02 Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19? Manni Luthra-Guptasarma, Purnananda Guptasarma
9 [GO] 2021―Jun―09 Air pollution and cardiovascular disease: Can the Australian bushfires and global COVID-19 pandemic of 2020 convince us to change our ways? Kathryn Wolhuter, Manish Arora, Jason C. Kovacic
10 [GO] 2021―Jun―04 SARS-CoV-2 infection and cancer Aureliano Stingi, Luca Cirillo
11 [GO] 2021―May―28 SARS-CoV-2′s claimed natural origin is undermined by issues with genome sequences of its relative strains Yuri Deigin, Rossana Segreto
12 [GO] 2021―Apr―29 Cancer as a prospective sequela of long COVID-19 Geetanjali Saini, Ritu Aneja
13 [GO] 2021―Apr―16 Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2 Alaa Shaheen
14 [GO] 2021―Apr―07 Two leading international congresses in Iran in the era of COVID-19: 21st royan international twin congress, 4th international and 16th Iranian genetics congress Leila Montazeri, Maryam Mohajeri, Hossein Baharvand, Rouhollah Fathi, Valeria Poli, Sara Kazemi, et al. (+4)
15 [GO] 2021―Mar―10 There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (https://doi.org/10.1002/bies.202000240) Alexander Tyshkovskiy, Alexander Y. Panchin
16 [GO] 2021―Feb―20 The cost of superficial values in a life-threatening pandemic: How globalization grates against evolution… Andrew Moore
17 [GO] 2020―Dec―30 Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera Constantin Pape, Roman Remme, Adrian Wolny, Sylvia Olberg, Steffen Wolf, Lorenzo Cerrone, et al. (+21)
18 [GO] 2020―Dec―18 The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients? Sven Kurbel
19 [GO] 2020―Nov―20 Strangers look sicker (with implications in times of COVID-19) Paola Bressan
20 [GO] 2020―Nov―17 The genetic structure of SARS-CoV-2 does not rule out a laboratory origin Rossana Segreto, Yuri Deigin
21 [GO] 2020―Nov―11 Why does COVID-19 pathology have several clinical forms? Fatemeh Aliabadi, Marjan Ajami, Hamidreza Pazoki-Toroudi
22 [GO] 2020―Nov―10 Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis? Preetam Basak, Naresh Sachdeva, Devi Dayal
23 [GO] 2020―Nov―09 Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial Hiroshi Katayama
24 [GO] 2020―Oct―11 Superposition of COVID-19 waves, anticipating a sustained wave, and lessons for the future Joel Weijia Lai, Kang Hao Cheong
25 [GO] 2020―Sep―22 Repurposing Vaccines in the Fight against COVID-19 Kang Hao Cheong
26 [GO] 2020―Sep―01 Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences? Robert Root-Bernstein
27 [GO] 2020―Aug―28 Beta-adrenergic Blockers as a Potential Treatment for COVID-19 Patients Natesan Vasanthakumar
28 [GO] 2020―Aug―12 Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture? Karl Sirotkin, Dan Sirotkin
 [1] 

28 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec